Assessing the role of nocturnal core body temperature dysregulation as a biomarker of neurodegeneration.

Parkinson’s disease circadian core body temperature dementia with Lewy bodies idiopathic rapid eye movement sleep behaviour disorder prodromal synucleinopathy

Journal

Journal of sleep research
ISSN: 1365-2869
Titre abrégé: J Sleep Res
Pays: England
ID NLM: 9214441

Informations de publication

Date de publication:
10 2020
Historique:
received: 13 06 2019
revised: 19 09 2019
accepted: 05 10 2019
pubmed: 13 11 2019
medline: 8 1 2021
entrez: 13 11 2019
Statut: ppublish

Résumé

The vast majority of patients with idiopathic rapid eye movement sleep behaviour disorder will develop a neurodegenerative α-synuclein-related condition, such as Parkinson's disease or dementia with Lewy bodies. The pathology underlying dream enactment overlaps anatomically with the brainstem regions that regulate circadian core body temperature. Previously, nocturnal core body temperature regulation has been shown to be impaired in Parkinson's disease. However, no study to date has investigated nocturnal core body temperature changes in patients with idiopathic rapid eye movement sleep behaviour disorder, which may prove to be an early objective biomarker for α-synucleinopathies. Ten healthy controls, 15 patients with idiopathic rapid eye movement sleep behaviour disorder, 31 patients with Parkinson's disease and six patients with dementia with Lewy bodies underwent clinical assessment and nocturnal polysomnography with core body temperature monitoring. A validated cosinor method was utilised for core body temperature analysis. No differences in mesor, nadir or time of nadir were observed between groups. However, when compared with healthy controls, the amplitude of the nocturnal core body temperature (mesor minus nadir) was significantly reduced in patients with idiopathic rapid eye movement sleep behaviour disorder, Parkinson's disease with concurrent rapid eye movement sleep behaviour disorder and dementia with Lewy bodies (p < 0.001, p = 0.043 and p = 0.017, respectively). Importantly, this relationship was not seen in those patients with Parkinson's disease without rapid eye movement sleep behaviour disorder. In addition, there was a significant negative correlation between amplitude of the core body temperature and self-reported rapid eye movement sleep behaviour disorder symptoms. Changes in thermoregulatory circadian rhythm may be specifically associated with the pathology underlying rapid eye movement sleep behaviour disorder rather than simply that of α-synucleinopathy. These findings implicate thermoregulatory dysfunction as a potential early biomarker for development of rapid eye movement sleep behaviour disorder-associated neurodegeneration, and suggest that subpopulations with differing pathological underpinnings might exist in Parkinson's disease.

Identifiants

pubmed: 31713306
doi: 10.1111/jsr.12939
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12939

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2019 European Sleep Research Society.

Références

American Academy of Sleep Medicine (2014). International classification of sleep disorders, 3rd edn. Darien, IL: American Academy of Sleep Medicine.
Benloucif, S., Guico, M. J., Reid, K. J., Wolfe, L. F., L’Hermite-Balériaux, M., & Zee, P. C. (2005). Stability of melatonin and temperature as circadian phase markers and their relation to sleep times in humans. Journal of Biological Rhythms, 20(2), 178-188. https://doi.org/10.1177/0748730404273983
Boeve, B. F. (2013). Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease. The Lancet Neurology, 12(5), 469-482. https://doi.org/10.1016/S1474-4422(13)70054-1
Boeve, B. F., Silber, M. H., Saper, C. B., Ferman, T. J., Dickson, D. W., Parisi, J. E., …, Braak, H. (2007). Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain, 130(11), 2770-2788. https://doi.org/10.1093/brain/awm056
Bolitho, S. J., Naismith, S. L., Terpening, Z., Grunstein, R. R., Melehan, K., Yee, B. J., …, Lewis, S. J. G. (2015). Investigating the night-to-night variability of REM without atonia in Parkinson's disease. Sleep Medicine, 16(1), 190-193. https://doi.org/10.1016/j.sleep.2014.08.007
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging, 24(2), 197-211. https://doi.org/10.1016/S0197-4580(02)00065-9
Breen, D. P., Vuono, R., Nawarathna, U., Fisher, K., Shneerson, J. M., Reddy, A. B., & Barker, R. A. (2014). Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurology, 71(5), 589-595. https://doi.org/10.1001/jamaneurol.2014.65
Chahine, L. M., Daley, J., Horn, S., Colcher, A., Hurtig, H., Cantor, C., & Dahodwala, N. (2013). Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson's disease. Movement Disorders, 28(8), 1146-1149. https://doi.org/10.1002/mds.25438
dos Santos, A. B., Kohlmeier, K. A., & Barreto, G. E. (2015). Are sleep disturbances preclinical markers of Parkinson's disease? Neurochemical Research, 40(3), 421-427. https://doi.org/10.1007/s11064-014-1488-7
Frauscher, B., Iranzo, A., Högl, B., Casanova-Molla, J., Salamero, M., Gschliesser, V., …, Santamaria, J. (2008). Quantification of electromyographic activity during REM sleep in multiple muscles in REM sleep behavior disorder. Sleep, 31(5), 724-731. https://doi.org/10.1093/sleep/31.5.724
Fuller, P. M., Gooley, J. J., & Saper, C. B. (2006). Neurobiology of the sleep-wake cycle: Sleep architecture, circadian regulation, and regulatory feedback. Journal of Biological Rhythms, 21, 482-493. https://doi.org/10.1177/0748730406294627
Gibb, W. R., & Lees, A. J. (1988). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 51(6), 745-752. https://doi.org/10.1136/jnnp.51.6.745
Iranzo, A., Fernández-Arcos, A., Tolosa, E., Serradell, M., Molinuevo, J. L., Valldeoriola, F., …, Santamaría, J. (2014). Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: Study in 174 patients. PLoS ONE, 9(2), e89741. https://doi.org/10.1371/journal.pone.0089741
Iranzo, A., Molinuevo, J. L., Santamaría, J., Serradell, M., Martí, M. J., Valldeoriola, F., & Tolosa, E. (2006). Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: A descriptive study. Lancet Neurology, 5(7), 572-577. https://doi.org/10.1016/S1474-4422(06)70476-8
Kordower, J. H., Olanow, C. W., Dodiya, H. B., Chu, Y., Beach, T. G., Adler, C. H., …, Bartus, R. T. (2013). Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease. Brain, 136(8), 2419-2431. https://doi.org/10.1093/brain/awt192
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., …, Kosaka, K. (2017). Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology, 89(1), 88-100. https://doi.org/10.1212/WNL.0000000000004058
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J. P., Weintraub, D. ,. …, Kosaka, K. (2017). Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. (1526-632X (Electronic)).
Nomura, T., Inoue, Y., Kagimura, T., Uemura, Y., & Nakashima, K. (2011). Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson’s disease patients. Sleep Medicine, 12(7), 711-713. https://doi.org/10.1016/j.sleep.2011.01.015
Pierangeli, G., Provini, F., Maltoni, P., Barletta, G., Contin, M., Lugaresi, E., …, Cortelli, P. (2001). Nocturnal body core temperature falls in Parkinson's disease but not in multiple-system atrophy. Movement Disorders, 16(2), 226-232. https://doi.org/10.1002/mds.1039
Postuma, R. B., & Berg, D. (2016). Advances in markers of prodromal Parkinson disease. Nature Reviews Neurology, 12(11), 622-634. https://doi.org/10.1038/nrneurol.2016.152
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., …, Deuschl, G. (2015). MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders, 30(12), 1591-1601. https://doi.org/10.1002/mds.26424
Postuma, R. B., Gagnon, J. F., Vendette, M., Fantini, M. L., Massicotte-Marquez, J., & Montplaisir, J. (2009). Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology, 72(15), 1296-1300. https://doi.org/10.1212/01.wnl.0000340980.19702.6e
Postuma, R. B., Iranzo, A., Hu, M., Högl, B., Boeve, B. F., Manni, R., …, Pelletier, A. (2019). Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: A multicentre study. Brain, 142(3), 744-759. https://doi.org/10.1093/brain/awz030
Schenck, C. H., Boeve, B. F., & Mahowald, M. W. (2013). Delayed emergence of a Parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: A 16-year update on a previously reported series. Sleep Medicine, 14(8), 744-748. https://doi.org/10.1016/j.sleep.2012.10.009
Stiasny-Kolster, K., Mayer, G., Schäfer, S., Möller, J. C., Heinzel-Gutenbrunner, M., & Oertel, W. H. (2007). The REM sleep behavior disorder screening questionnaire-A new diagnostic instrument. Movement Disorders, 22(16), 2386-2393. https://doi.org/10.1002/mds.21740
Szeto, J. Y. Y., Mowszowski, L., Gilat, M., Walton, C. C., Naismith, S. L., & Lewis, S. J. G. (2015). Assessing the utility of the movement disorder society task force level 1 diagnostic criteria for mild cognitive impairment in parkinson's disease. Parkinsonism and Related Disorders, 21(1), 31-35. https://doi.org/10.1016/j.parkreldis.2014.10.020.
Videnovic, A., & Willis, G. L. (2016). Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease? Movement Disorders, 31(3), 260-269. https://doi.org/10.1002/mds.26509
Zhong, G., Bolitho, S., Grunstein, R., Naismith, S. L., & Lewis, S. J. (2013). The relationship between thermoregulation and REM sleep behaviour disorder in Parkinson’s disease. PLoS ONE, 8(8), e72661. https://doi.org/10.1371/journal.pone.0072661
Zhong, G., Naismith, S. L., Rogers, N. L., & Lewis, S. J. G. (2011). Sleep-wake disturbances in common neurodegenerative diseases: A closer look at selected aspects of the neural circuitry. Journal of the Neurological Sciences, 307(1-2), 9-14. https://doi.org/10.1016/j.jns.2011.04.020

Auteurs

Arabella K Raupach (AK)

Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Camperdown, New South Wales, Australia.

Kaylena A Ehgoetz Martens (KA)

Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Camperdown, New South Wales, Australia.
Department of Kinesiology, University of Waterloo, Waterloo, Ontario, Canada.

Negar Memarian (N)

Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Camperdown, New South Wales, Australia.
CIRUS, Sleep and Circadian Group, Woolcock Institute of Medical Research, Glebe, New South Wales, Australia.

George Zhong (G)

Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Camperdown, New South Wales, Australia.
Department of Anaesthesia, Concord Repatriation General Hospital, Concord, New South Wales, Australia.

Elie Matar (E)

Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Camperdown, New South Wales, Australia.

Glenda M Halliday (GM)

Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Camperdown, New South Wales, Australia.

Ronald Grunstein (R)

CIRUS, Sleep and Circadian Group, Woolcock Institute of Medical Research, Glebe, New South Wales, Australia.

Simon J G Lewis (SJG)

Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Camperdown, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH